**Core tip:** We investigated the correlation between iodine concentration (IC) value generated from spectral computed tomography (CT) and angiogenesis in gastric cancer (GC) with clinical-pathological data. Our results showed that normalized IC (nIC) in both the arterial (AP) and venous phases (VP) had a positive linear correlation with micro-vessel density. nIC-AP reflected the angiogenesis in relatively earlier and well-differentiated GC, while nIC-VP reflected this in further advanced and poorly differentiated GC. Spectral CT with quantitative IC value offers a new choice for evaluating the angiogenesis of gastric cancer noninvasively.

INTRODUCTION
============

Despite a recent decrease, gastric cancer (GC) remains the most common cancer and is the third leading cause of cancer-related death globally\[[@B1]\]. In China, the incidence and mortality rates of GC remain high, and the vast majority of cases are in the advanced stage\[[@B2]\], which requires more attention.

Angiogenesis is fundamental to the growth, invasion, and metastasis of GC, and greatly influences the response to anti-tumor therapies\[[@B3]\]. To date, the standard method for studying angiogenesis has been histopathological counting of micro-vessel density (MVD), which is specimen- and immunostaining-dependent. This is impractical in advanced patients undergoing anti-angiogenesis or chemotherapy. Compared with MVD counting, using preoperative imaging modalities for the noninvasive assessment of tumor angiogenesis is more acceptable and feasible. A previous study has revealed that MVD, vascular endothelial growth factor (VEGF), and the absolute enhanced value show some positive correlations with conventional contrast-enhanced computed tomography (CT)\[[@B4]\]. Additionally, CT perfusion has shown the potential for evaluating tumor angiogenesis\[[@B5],[@B6]\], but the complicated measurement and high radiation dosage have limited the extensive application of CT in this regard.

The recently developed spectral CT yields material-decomposition (MD) images that can quantitatively map the iodine concentration (IC) of the tissue in enhanced images. This IC value has been proven to show a strong correlation with the actual iodine concentration in the phantom\[[@B7]\]. Recently, preliminary studies have reported the use of the IC value to differentiate benign and malignant lesions, to find embolisms, and to evaluate the efficacy of anticancer therapy\[[@B8]-[@B11]\]. Particularly in the evaluation of neoadjuvant chemotherapy of GC, the IC value was proven to be a more robust imaging biomarker than the morphology index\[[@B11]\]. However, it was not clear how this correlated with radiological-pathological features. On the other hand, the IC value has shown a correlation with vascularization in solid tumors, such as pancreatic carcinoma, hepatocarcinoma, and non-small-cell lung cancer\[[@B12]-[@B14]\], while there has been no such report for GC, to provide a basis for using image indicators, other than morphology, for assessing chemo-efficacy. Therefore, our purpose was to investigate the correlation between IC value and angiogenesis in GC cases with clinical-pathological data.

MATERIALS AND METHODS
=====================

Study population
----------------

Adult patients with advanced GC confirmed by endoscopic biopsy, who were scheduled for surgery, were enrolled. This study was approved by the institutional review board, and informed consent was obtained from each participant. All procedures were performed in accordance with the ethical standards of the institution.

Exclusion criteria were: (1) allergies to intravenous contrast media; (2) cardiac or renal insufficiency; (3) history of chemotherapy or radiotherapy; (4) inability to visualize the tumor on CT; (5) early tumor staging (T1) or presence of distant metastasis (M1); and (6) specimen with poor fixation for immunostaining.

From June 2014 to May 2015, a total of 41 patients prospectively underwent spectral CT examination. Of these, two patients with serious interface artifacts on CT images, one patient with tumor tissue necrosis that influenced MVD counting, one patient with no tumor cells on hematoxylin and eosin (HE) slices, and three patients with failed immunostaining were excluded.

Ultimately, the data of 34 patients were collected and statistically analyzed. Patient records and pathological data, including gender, age, tumor size, tumor location, invasion depth, lymph nodes involvement, Lauren subtypes, and differentiation, were documented.

CT scan methods
---------------

After fasting overnight, all patients were administered 10 mg anisodamine (Minsheng Pharmaceutical Group Co., Ltd., Hangzhou, China) intramuscularly to reduce gastrointestinal motility 20 min prior to CT examination, and ingested 800-1000 mL of water to distend the stomach. During scanning, patients were instructed to suspend respiration.

All examinations were performed on a Discovery CT750 HD system (GE Healthcare, Milwaukee, WI, United States), and included bi-phasic enhanced spectral scanning in the arterial and venous phases (AP and VP, respectively). Spectral CT imaging was performed with a 0.5 ms switch of tube voltage between 140 kVp and 80 kVp; a rotation speed of 0.6 s, and a helical pitch of 1.375:1. The scan range was from the diaphragmatic dome to the symphysis pubis. Non-ionic contrast material, iohexol (350 mg I/mL, GE Pharmaceutical, Shanghai of China), at 1.3 mL per kilogram of body weight was used (total volume: 60-110 mL) at a flow rate of 2.5-4.5 mL/s was injected *via* a peripheral vein, using a dual high-pressure syringe. The AP acquisition time was triggered at 9 s after the attenuation of diaphragmatic abdominal aorta reached 100 HU (SmartPrep; GE Healthcare). The VP followed with a 30 s interval. Raw data were reconstructed to 1.25-mm slice images, using decompose projection-based software. An additional 40% adaptive statistical iterative reconstruction algorithm was applied to suppress image noise and decrease the radiation dose required for spectral CT.

Image analysis
--------------

All CT images were transferred to a commercially available workstation (Advantage Windows 4.6; GE Medical Systems, Chicago, IL, United States) to generate iodine-based MD images (Figures [1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}). Two experienced radiologists (J.G. and P.L., with 25 and 5 years of experience with abdominal CT, respectively), who were blinded to the pathological results, analyzed the images. Three manually drawn regions of interests (ROIs) that encompassed the maximum lesion in the consecutive 1.25-mm layers of bi-phasic axial images were measured. Areas containing prominent artifacts, necrosis, and vessels were carefully avoided (mean square: 871 mm^2^; range: 122-1308 mm^2^). For the normal site, we chose a distance longer than 5 cm from the lesion edge that was thick enough to place the ROI. Three small circular ROIs with a diameter exceeding 2 mm were measured as ROI-normal. Images were compared to ensure the measurements were as consistent as possible in both phases. The ICs in the AP (IC-AP) and in the VP (IC-VP) were generated simultaneously (unit: 100 μg/mL). At the same time, a round ROI was placed on the abdominal aorta in the same layer as the target, to calculate the normalized IC (nIC = IC~target~/IC~aorta~)\[[@B15]\], aiming to reduce the individual circulatory variability. All the ICs and nICs obtained from the same patient were averaged and disagreement on measurement was resolved by consensus.

![Detection of the iodine concentration value in a 51-year-old man with poorly differentiated adenocarcinoma, with staging IIIc (T4aN3M0). A: The monochromatic image shows focal wall thickening in the gastric antrum; B: The iodine-water image with iodine concentration (IC) value 12.83 (100 µg/cm^3^), normalized IC (nIC) value 0.11 in the arterial phase. Monochromatic image (C) and iodine-water image (D) with IC value 23.91 (100 µg/cm^3^), nIC value 0.53 in the venous phase; E: Hematoxylin and eosin staining of a pathological section obtained from radical surgery shows poorly differentiated, diffused subtype in the Lauren classification (× 400); F: CD34-staining shows endothelial cells stained brown; micro-vessels form clusters or have tiny hollow lumens (micro-vessel density 45/magnification × 400). G: Weak vascular endothelial growth factor staining in the cytoplasm (× 400) with score 2.](WJG-23-1666-g001){#F1}

![Detection of iodine concentration value in a 50-year-old man with moderate differentiated adenocarcinoma, of staging IIIa (T4aN1M0). A: Monochromatic image shows focal wall thickening in the gastric cardia and lesser curvature; B: The iodine-water image with iodine concentration (IC) value 11.78 (100 µg/cm^3^), normalized IC (nIC) value 0.09 in the arterial phase; Monochromatic image (C) and (D) iodine-water image with IC value 18.63 (100 µg/cm^3^), nIC value 0.34 in the venous phase; E: Hematoxylin and eosin staining shows a moderately differentiated, intestinal Lauren subtype (× 400); F: Immunohistochemical staining shows CD34 positive micro-vessel (micro-vessel density count: 27/magnification × 400); G: Strongly positive vascular endothelial growth factor staining (× 400) with score 5.](WJG-23-1666-g002){#F2}

Histopathologic evaluation
--------------------------

A surgeon (K.R) and a radiologist (X.C) performed sampling together to guarantee that the specimen and the ROI were from virtually the same level, by re-examining the axial and multi-planar reconstruction images. The distance to the cardia or pylorus of the sample site and the thickness were compared on both CT images and surgical specimens. Then, the selected samples (tumor and normal wall) were fixed overnight in 10% formalin, and subsequently dehydrated in alcohol and paraffin-embedded. Wax blocks comprising the central part of the adenocarcinoma were sectioned into 4-μm-thick slices. A ready-to-use two-step streptavidin-peroxidase method was applied. The mouse anti-CD34 monoclonal antibody (diluted 1:150) and rabbit anti-VEGF-A polyclonal antibody (diluted 1:200) (Beijing Zhongshan Goldenbridge Company, Beijing, China) were used to stain all pathological tissues. Positive and negative immunohistochemistry controls were prepared as routine. A pathologist (K.C, with 25 years\' experience in MVD and VEGF immunostaining), who was blinded to the spectral CT imaging results, performed the counting and evaluation of all slides.

MVD counting was performed using the Weidner method\[[@B16]\]. The area where vascular endothelial cells stained most intensively was first identified at low (× 100) magnification. Then, five fields were randomly selected at × 400 magnification to count the CD34-positive cell clusters and the mean was recorded as the final value (Figures [1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}). VEGF (stained brown), located in the cytoplasm, was scored using an established method\[[@B17]\]: scores of the percentage of positive tumor cells and signal intensity were summed. If the score was less than 4, the section was considered negative, whereas a score of 4 or more was considered positive (Figures [1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}).

Statistical analysis
--------------------

All statistical procedures were performed with a software package (SPSS 21.0, Chicago, IL, United States). A *P*-value of less than 0.05 was considered to indicate a statistically significant difference. Nodal status was classified as positive and negative for lymph node metastasis, and the depth of invasion was classified as positive and negative serosal involvement. A single highly differentiated patient was grouped together with the moderately differentiated patients. Data were subjected to a Kolmogorov-Smirnov normality test and continuous variables were presented as means and standard errors of the mean. When analyzing the correlation of nIC and MVD and VEGF, scatter plots were made first between continuous variables, followed by the Pearson or the Spearman rank-correlation test (Figure [3](#F3){ref-type="fig"}). Student\'s *t*-test, correct *t* test, and one-way analysis of variance (ANOVA)-LSD test were performed to analyze differences in categorical data between groups (serosal involvement, lymph node metastasis, histologic differentiation, Lauren subtype, tumor location, and gender).

![**Scatter plots of normalized iodine concentration in arterial phase, normalized iodine concentration in venous phase, and microvessel density counts in tumor lesions (*r* = 0.423 for normalized iodine concentration in arterial phase, *r* = 0.606 for normalized iodine concentration in venous phase).** VEGF: Vascular endothelial growth factor; nIC: Normalized iodine concentration; nIC-AP: nIC-arterial phase; nIC-VP: nIC-venous phase; MVD: Microvessel density.](WJG-23-1666-g003){#F3}

RESULTS
=======

A total of 34 advanced GC patients (23 males, 11 females; mean age: 56 ± 3.7 years; age range: 30-73 years) were included (Table [1](#T1){ref-type="table"}). Tumor size ranged from 1.5 cm to 13.0 cm (median: 4.0 cm). Fourteen tumors located in the gastric cardia-fundus, nine in the gastricum, and 11 in antrum. All patients were treated surgically by radical gastrectomy and D2 lymph node dissection. Based on pathologic results, the adenocarcinoma was well differentiated in one patient, moderately differentiated in 16 patients, and poorly differentiated in 17 patients. According to the 7^th^ American Joint Committee on staging classification (AJCC), five patients were classified as T2, two as T3, twenty-two as T4a and five as T4b; eleven as N0, eight as N1, seven as N2, and eight as N3. No patient had distant metastasis. The Lauren classification was as follows: 15 were intestinal type, seven were mixed type, and 12 were diffuse type. Additionally, the immunostaining analysis revealed that 25 patients (73.53%) stained positive for VEGF with a score of 4 (*n* = 11), 5 (*n* = 9), or 6 (*n* = 5). The mean MVD count for these 34 tumors was 26.94 ± 1.35.

###### 

Clinical characteristics of the patients (*n* = 34)

  ---------------------- ------------------------------ ---- --------
  Sex                    Male                           23   67.65%
                         Female                         11   32.35%
  Age                    30 -73 yr (56 ± 3.7 yr)             
  Size                   1.5 -13.0 cm (median 4.0 cm)        
  Tumor location         Cardia/Fundus                  14   41.18%
                         Gastricum                      9    26.47%
                         Antrum                         11   32.35%
  Nodal status           N0                             11   32.35%
                         N1                             8    23.53%
                         N2                             7    20.59%
                         N3                             8    23.53%
  Depth of invasion      pT2                            5    14.71%
                         pT3                            2    5.89%
                         pT4a                           22   64.71%
                         pT4b                           5    14.71%
  Lauren subtype         Intestinal type                15   44.12%
                         Mixed type                     7    20.59%
                         Diffuse type                   12   35.29%
  Histological grading   Highly differentiated          1    2.38%
                         Moderately differentiated      16   47.06%
                         Poorly differentiated          17   50.00%
  ---------------------- ------------------------------ ---- --------

In general, the bi-phasic nIC values and the MVD counts were positively correlated (*P =* 0.013, *P \<* 0.001, respectively). VEGF did not correlate with either nIC value or with MVD, as shown in Table [2](#T2){ref-type="table"}. When stratified by different clinical features, the correlation coefficient value increased. nIC-AP positively correlated with MVD in patients with tumor stage less than T4 (*r* = 0.851, *P =* 0.015), tumor of N0 stage (*r* = 0.620, *P =* 0.042), with a tumor located in the pylorus region (*r* = 0.616, *P =* 0.044), and who were female (*r* = 0.696, *P =* 0.017). On the other hand, nIC-VP correlated with MVD in the more advanced group of patients, with tumors above T4 stage (*r* = 0.656, *P \<* 0.001), with nodular involvement (*r* = 0.644, *P =* 0.001), that were poorly differentiated (*r* = 0.799, *P \<* 0.001), were of mixed and diffused Lauren subtypes (*r* = 0.827, *P =* 0.022; *r* = 0.765, *P =* 0.004, respectively), and male gender (*r* = 0.606, *P =* 0.002), as shown in Table [3](#T3){ref-type="table"}.

###### 

Correlation of nIC values, microvessel density and vascular endothelial growth factor expression

  **Varieties**   **MVD**   **VEGF**                                        
  --------------- --------- --------------------------------------- ------- -------
  nIC-AP          0.423     0.013[a](#T2FN1){ref-type="table-fn"}   0.170   0.358
  nIC-VP          0.606     0.000[a](#T2FN1){ref-type="table-fn"}   0.311   0.073
  MVD             1.000                                             0.210   0.233

*P* \< 0.05. nIC-AP: Normalized iodine concentration in arterial phase; nIC-VP: Normalized iodine concentration in venous phase; MVD: Microvessel density; VEGF: Vascular endothelial growth factor.

###### 

Correlations between bi-phase normalized iodine concentration and microvessel density in different clinical-pathological subgroups

  **Varieties**                          ***n***   **nIC-AP *vs* MVD**   **nIC-VP *vs* MVD**                             
  -------------------------------------- --------- --------------------- --------------------------------------- ------- ---------------------------------------
  Depth of invasion                                                                                                      
  \< T4                                  7         0.851                 0.015[a](#T3FN1){ref-type="table-fn"}   0.600   0.154
  T4                                     27        0.370                 0.057                                   0.656   0.000[a](#T3FN1){ref-type="table-fn"}
  Nodal status                                                                                                           
  N0                                     11        0.620                 0.042[a](#T3FN1){ref-type="table-fn"}   0.600   0.051
  N1-3                                   23        0.330                 0.124                                   0.644   0.001[a](#T3FN1){ref-type="table-fn"}
  Histologic differentiation                                                                                             
  Highly and Moderately differentiated   17        0.250                 0.334                                   0.190   0.466
  Poorly differentiated                  17        0.427                 0.087                                   0.799   0.000[a](#T3FN1){ref-type="table-fn"}
  Lauren subtype                                                                                                         
  Intestinal type                        15        0.222                 0.427                                   0.101   0.719
  Mixed type                             7         0.741                 0.057[a](#T3FN1){ref-type="table-fn"}   0.827   0.022[a](#T3FN1){ref-type="table-fn"}
  Diffuse type                           12        0.145                 0.653                                   0.765   0.004[a](#T3FN1){ref-type="table-fn"}
  Tumor location                                                                                                         
  Cardia/Fundus                          14        0.311                 0.279                                   0.760   0.796
  Gastricum                              9         0.385                 0.307                                   0.507   0.163
  Antrum                                 11        0.616                 0.044[a](#T3FN1){ref-type="table-fn"}   0.891   0.000[a](#T3FN1){ref-type="table-fn"}
  Sex                                                                                                                    
  Male                                   23        0.385                 0.070                                   0.606   0.002[a](#T3FN1){ref-type="table-fn"}
  Female                                 11        0.696                 0.017[a](#T3FN1){ref-type="table-fn"}   0.605   0.049

*P* \< 0.05. nIC-AP: Normalized iodine concentration in arterial phase; nIC-VP: Normalized iodine concentration in venous phase; MVD: Microvessel density.

The nIC values in the primary GC and normal gastric wall were 0.116 ± 0.033 and 0.101 ± 0.023 in arterial phase (*P =* 0.033), 0.386 ± 0.061, and 0.286 ± 0.066 in the venous phase (*P \<* 0.001) (Figure [4A](#F4){ref-type="fig"}). For the VEGF-positive and -negative group, neither nIC-AP nor nIC-VP showed statistically significant differences (Figure [4B](#F4){ref-type="fig"}).

![Comparison of normalized iodine concentration in arterial phase; and normalized iodine concentration in venous phase between the normal gastric wall and tumor site (A); comparison of normalized iodine concentration in arterial phase and normalized iodine concentration in venous phase between the vascular endothelial growth factor-positive and -negative group (B). ^a^*P* \< 0.05, ^b^*P* \< 0.001. VEGF: Vascular endothelial growth factor; nIC: Normalized iodine concentration; AP: Arterial phase; VP: Venous phase.](WJG-23-1666-g004){#F4}

When stratified by clinical subgroups, both nIC-AP and nIC-VP were higher in patients with serosal involvement, lymph node metastasis, poor differentiation, and diffused Lauren type than in those with depth invasion under T4, nodal status N0, high and moderate differentiation, intestinal and mixed Lauren type, but these differences did not reach statistical significance. nIC-AP and nIC-VP showed statistically significant differences between differentiation categories (*P =* 0.003, *P =* 0.001, respectively) and between Lauren subtypes (*P =* 0.016, *P =* 0.006, respectively). The LSD test revealed that nIC-AP and nIC-VP were significantly different between intestinal and diffuse Lauren subtypes (*P =* 0.005, *P =* 0.004, respectively). nIC-VP was also significantly different between intestinal and mixed Lauren subtypes (*P =* 0.013), as shown in Table [4](#T4){ref-type="table"}.

###### 

Difference of bi-phase normalized iodine concentration between different clinical-pathological subgroups

  **Varieties**                          ***n***   **nIC-AP**      **nIC-VP**                                                                              
  -------------------------------------- --------- --------------- ----------------------------------------------------------------------- --------------- -----------------------------------------------------------------------
  Depth of invasion                                                                                                                                        
  \< T4                                  7         0.101 ± 0.042   0.195                                                                   0.363 ± 0.079   0.302
  \> T4                                  27        0.120 ± 0.031                                                                           0.392 ± 0.063   
  Nodal status                                                                                                                                             
  N0                                     11        0.112 ± 0.033   0.321                                                                   0.385 ± 0.085   0.923
  N1-3                                   23        0.125 ± 0.035                                                                           0.387 ± 0.057   
  Histologic differentiation                                                                                                                               
  Highly and moderately differentiated   17        0.100 ± 0.028   0.003[a](#T4FN3){ref-type="table-fn"}                                   0.352 ± 0.048   0.001[a](#T4FN3){ref-type="table-fn"}
  Poorly differentiated                  17        0.132 ± 0.031                                                                           0.421 ± 0.065   
  Lauren subtype                                                                                                                                           
  Intestinal type                        15        0.099 ± 0.029   0.016[a](#T4FN3){ref-type="table-fn"}                                   0.347 ± 0.048   0.006[a](#T4FN3){ref-type="table-fn"}
  Mixed type                             7         0.120 ± 0.032                                                                           0.417 ± 0.061   0.013[1](#T4FN1){ref-type="table-fn"}[a](#T4FN3){ref-type="table-fn"}
  Diffuse type                           12        0.135 ± 0.030   0.005[2](#T4FN2){ref-type="table-fn"}[a](#T4FN3){ref-type="table-fn"}   0.417 ± 0.067   0.00[2](#T4FN2){ref-type="table-fn"}[a](#T4FN3){ref-type="table-fn"}
  Tumor location                                                                                                                                           
  Cardia/Fundus                          14        0.109 ± 0.033   0.445                                                                   0.385 ± 0.046   0.874
  Gastricum                              9         0.128 ± 0.024                                                                           0.387 ± 0.064   
  Antrum                                 11        0.116 ± 0.040                                                                           0.387 ± 0.091   
  Sex                                                                                                                                                      
  Male                                   23        0.113 ± 0.033   0.377                                                                   0.390 ± 0.069   0.633
  Female                                 11        0.124 ± 0.035                                                                           0.378 ± 0.062   

One-way ANOVA-LSD, mixed type *vs* intestinal type;

Diffuse type *vs* intestinal type.

*P* \< 0.05. nIC-AP: Normalized iodine concentration in arterial phase; nIC-VP: Normalized iodine concentration in venous phase; MVD: Microvessel density; SD: Standard deviation.

DISCUSSION
==========

There were four major findings from this study. First, the bi-phasic nICs showed a significantly linear positive relationship with MVD in primary GC. The nIC-AP and nIC-VP correlated with MVD in different subgroups; the former correlated significantly with MVD in the relative earlier stage of advanced GC, while the latter correlated with MVD in the more advanced stage. Second, no significant correlation was found between nICs and VEGF. Third, nIC values in the normal gastric wall were observed to be significant lower than that in the tumor. Fourth, nICs were observed to differ between histological grades and Lauren subtypes of advanced GC; the greater the malignancy, the higher the nICs. Taken together, these observations demonstrate that quantification of iodine in spectral CT imaging have the potential to reflect angiogenesis of advanced GC.

Iodine, a commonly used CT contrast material, is generally known to produce higher attenuation at low tube voltage settings\[[@B18]\]. Based on this effect, spectral CT using high and low voltage switching settings could differentiate materials of the same density\[[@B19]\] and the IC value could be extracted\[[@B20]\]. With water-iodine based material decomposition images, Lv et al\[[@B9]\] concluded that the IC in images of hepatic lesions acquired in a quantitative parameter was highly precise. Thieme et al\[[@B21]\] found a very good correlation between vessel occlusion depicted at CTA and IC defects in the dual-energy image, indicating that iodine distribution in the parenchyma is closely related to pulmonary perfusion. Therefore, the IC may be considered as an indirect marker of perfusion and tumor vascularity.

Tumor angiogenesis is defined as the formation of new blood vessels from pre-existing vessels\[[@B22]\]. MVD and identification of VEGF in tissues are commonly used biomarkers of angiogenesis\[[@B23]\]. In previous studies, the relationships between dynamic contrast-enhanced perfusion CT parameters and immunohistological markers of angiogenesis have been studied in different tumors, including colorectal cancer\[[@B24]\], advanced GC\[[@B6],[@B25]\], lung cancer\[[@B26]\], *etc*. However, the studies produced discrepant results on whether the use of blood flow or permeability surface area product were efficacious.

Our results proved a positive linear relationship between IC and MVD in primary GC. The nIC values were significantly elevated in the tumor as compared to the normal gastric wall. Similar results were acquired by Pang et al\[[@B27]\], who considered the nIC value of the infarcted myocardium to be an important indicator of MVD in the 1-min and 3-min CT images. Additionally, the study by Hu et al\[[@B12]\] indicated that the nIC values of three-phase scans had a positive correlation with MVD for detecting the therapeutic response in a pancreatic carcinoma xenograft nude mouse model. Taken together, spectral CT imaging can be used to evaluate angiogenesis in disease.

On the other hand, nIC had a low correlation with VEGF expression, and no significant differences were found in the comparison between IC parameters and VEGF group. VEGF, one of the most prominent biomarkers of angiogenesis studied to date, has been shown to correlate well with CT perfusion in peripheral pulmonary nodules\[[@B28]\]. Moreover, the study of Zhou et al\[[@B13]\] in a rabbit VX2 liver model suggested that nIC and contrast-enhanced ultrasound parameters positively correlated with VEGF and FGF2 expression, while several reports failed to show such a correlation, for example, the GC study performed by Yao et al\[[@B6]\] and the colorectal cancer research by Goh et al\[[@B24]\]. The relationship between VEGF expression and imaging of tumor vascularity is complex. Further investigations of IC and VEGF in a large population with different clinical-pathology are needed.

At the same time, nIC in arterial phase and venous phase displayed different character when stratified. The nIC-AP showed correlations with MVD in relative earlier and differentiated advanced GC, while nIC-VP correlated with MVD in more advanced stage and poorly differentiated advanced GC.

In terms of the acquisition time of our routine abdominal CT scanning, the AP was performed at about 25-30 s after contrast media injection, when the mucosa at the lesion presented as a focal enhanced line. nIC-AP can reflect the blood supply and functional capillary density. In the VP of GC, the markedly increased interstitial fibrous tissue reduced the flow-out speed of the contrast media\[[@B29]\]; thus, more dysfunctional neo-vessels should be considered. Therefore, the nIC-VP may represent the distribution of iodine in interstitial spaces. Under such conditions, the bi-phasic nIC demonstrated the vascular character of GC, and nIC-VP may be better correlated with MVD in advanced GC.

Furthermore, both nICs were different between histological differentiations and Lauren subgroups. The nIC-VP was more effective than nIC-AP in displaying the difference between Lauren subtypes. In general, the nIC value was higher in poorly differentiated and diffused types than that in highly or moderately differentiated and intestinal types. A previous study\[[@B30]\] has found that the degree of tumor angiogenesis was closely related to the pathological grade, that is, the poorer the differentiation of the tumor, the higher the MVD values. Another study\[[@B31]\] demonstrated a correlation between MVD and tumor histological type according to the Lauren classification. Accordingly, it is likely that the nIC value can be used to evaluate histology by mapping the neovascularization of advanced GC. The finding in the present study was also supported by the results of Pan et al\[[@B15]\] and Wang et al\[[@B32]\] in GC research.

The nICs increased in patients with serosal involvement and lymphatic metastasis, but the differences from patients without serosal involvement and lymphatic metastasis did not reach significant difference, for reasons that are not immediately clear, as these clinical-pathological features should reflect the functional status of the vasculature. Both nIC-AP and nIC-VP correlated with MVD of GC located in the antrum and occurring in different genders. However, nICs were not very effective in differentiating between these groups.

There are several potential limitations in our study. First, the tumor vasculature is spatially heterogeneous. Although we selected specimens carefully under the guide of two major specialists, the excision level was barely achieved. It may be questioned whether the part of the histopathological part selected and matched to the imaging measurement represented the angiogenesis of the whole tumor. Second, the sample numbers were limited, especially when subdivided by clinical classification. A larger prospective investigation is needed to confirm the present findings. Third, given the limitations of CT resolution, flat and light ulcerous lesions without enhancement would have been missed in the images, which inducing selection bias.

In conclusion, the bi-phasic nIC values had a positive linear correlation with MVD. nIC-AP reflected the angiogenesis in relatively earlier and well-differentiated advanced GC, while nIC-VP reflected this in further advanced and poorly differentiated GC. Spectral CT with quantitative IC value offers a new choice to evaluate the angiogenesis of gastric cancer noninvasively.

COMMENTS
========

Background
----------

Angiogenesis is fundamental to the growth, invasion, and metastasis of gastric cancer (GC). To date, the standard method for studying angiogenesis has been histopathological counting of micro-vessel density (MVD). This is impractical for patients who undergoing anti-angiogenesis or chemotherapy. The current trial was designed to evaluate if the iodine concentration (IC) generated by spectral computed tomography could non-invasively judge the features of tumoral MVD and vascular endothelial growth factor with clinical data.

Research frontiers
------------------

Iodine-water material-decomposition (MD) images can quantitatively map the IC of the tissue in enhanced scanning. In this study, there is suggestion that IC value has the potential to reflect angiogenesis of advanced GC.

Innovations and breakthroughs
-----------------------------

The authors measured the normalized IC value in spectral computed tomography (CT) with manually drawn regions of interests to avoid the selection bias. Data stratified by clinical subgroups further revealed the connection between imaging index and patho-index. They finally proved that the normalized IC value in different scanning phase could reflect angiogenesis in different pathological subgroups of advanced GC.

Applications
------------

Radiological-pathological correlation in angiogenesis, although with not much high coefficient, will offer a new choice to clinical decision in judging the status of GC, especially for neoadjuvant chemotherapy or radiochemotherapy patients.

Terminology
-----------

IC: Iodine is a commonly used contrast material in performing enhanced CT scanning. The iodine concentration here refers an imaging data, representing iodine distribution of the organ with spectral CT modality, not the real iodine concentration of contrast material itself.
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